4//SEC Filing
Turitz Andrew 4
Accession 0001477449-24-000041
CIK 0001477449other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:08 PM ET
Size
30.9 KB
Accession
0001477449-24-000041
Insider Transaction Report
Form 4
Turitz Andrew
SVP - Business Development
Transactions
- Sale
Common Stock
2024-03-01$15.06/sh−475$7,154→ 25,193 total - Exercise/Conversion
Common Stock
2024-03-01+4,226→ 29,419 total - Exercise/Conversion
Common Stock
2024-03-01+437→ 29,856 total - Exercise/Conversion
Common Stock
2024-03-01+867→ 30,723 total - Exercise/Conversion
Common Stock
2024-03-01+1,348→ 32,071 total - Exercise/Conversion
Common Stock
2024-03-01+12,400→ 44,471 total - Exercise/Conversion
Common Stock
2024-03-01+1,148→ 45,619 total - Sale
Common Stock
2024-03-04$14.52/sh−6,190$89,854→ 39,429 total - Award
Performance Stock Units
2024-03-01+12,679→ 12,679 total→ Common Stock (12,679 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−4,226→ 8,453 total→ Common Stock (4,226 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−437→ 0 total→ Common Stock (437 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−867→ 0 total→ Common Stock (867 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−1,348→ 5,392 total→ Common Stock (1,348 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−12,400→ 24,802 total→ Common Stock (12,400 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−1,148→ 0 total→ Common Stock (1,148 underlying)
Footnotes (13)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023.
- [F10]On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
- [F11]On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F12]On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F13]On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- [F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis
- [F3]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F4]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F5]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- [F6]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- [F7]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F8]On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F9]On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
Documents
Issuer
Teladoc Health, Inc.
CIK 0001477449
Entity typeother
Related Parties
1- filerCIK 0001726221
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:08 PM ET
- Size
- 30.9 KB